Almirall to collaborate with Spanish research center on skin cancer treatment
In a new strategic collaboration, Spanish dermatology company Almirall and the Center for Genomic Regulation will work on identifying new treatments for non-melanoma skin cancer.
by albert rønning-andersson, translated by kristoffer grønbæk
Spanish dermatology group Almirall and the research institution Center for Genomic Regulation have agreed to collaborate on developing and characterizing new pre-clinical models that can partake in finding new treatments for non-melanoma skin cancer (NMSC), Almirall informs in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Almirall expanding in the Nordics – ramps up hiring
For subscribers
Almirall's first-quarter Wynzora sales exceed EUR 3m
For subscribers
